J. Halperin
Artificial Intelligence · 2000–2020
A researcher in the Science corpus: 40 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Artificial Intelligence — 31 citations into it
- Statistics and Probability — 21 citations into it
Whom J. Halperin trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- John K. Kruschke (in Artificial Intelligence)
Papers from J. Halperin's perspective
Ordered by how strongly the researchers J. Halperin trusts endorse each paper. Same corpus, a different order for every researcher.
- Deep Residual Learning for Image Recognition (Computer Vision and Pattern Recognition)
- Mastering the game of Go with deep neural networks and tree search
- Inception-v4, Inception-ResNet and the Impact of Residual Connections on Learning
- Newly identified events in the RE-LY trial. (New England Journal of Medicine)
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation (Annals of Internal Medicine)
- Bayesian data analysis.
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. (New England Journal of Medicine)
- Dynamic Routing Between Capsules
- Sudden death due to cardiac arrhythmias. (New England Journal of Medicine)
- The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.
Their papers
- Machine learning prediction in cardiovascular diseases: a meta-analysis (2020) — 412 citations
- Deep learning for cardiovascular medicine: a practical primer. (2019) — 370 citations
- Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. (2014) — 935 citations
- 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) — 1,630 citations
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults (2013) — 3,746 citations
- Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial (2013) — 625 citations
- 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. (2013) — 1,418 citations
- 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013) — 3,814 citations
- Edoxaban versus warfarin in patients with atrial fibrillation. (2013) — 4,723 citations
- A pharmacogenetic versus a clinical algorithm for warfarin dosing. (2013) — 727 citations
- Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012) — 995 citations
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 1,012 citations
- 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 597 citations
- 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the Europe (2011) — 871 citations
- 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi (2011) — 687 citations
- Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. (2011) — 1,096 citations
- Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. (2011) — 625 citations
- 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) — 1,867 citations
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. (2011) — 5,282 citations
- Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort (2010) — 519 citations